Editorial: Second Line Treatment of Non-Small Cell Lung Cancer: Clinical, Pathological and Molecular Aspects of Novel Promising Drugs

Editorial: Second Line Treatment of Non-Small Cell Lung Cancer: Clinical, Pathological and Molecular Aspects of Novel Promising Drugs

Bibliographic Details
Main Authors:	Umberto Malapelle, Pierlorenzo Pallante
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2017-05-01
Series:	Frontiers in Medicine
Subjects:	NSCLC liquid biopsy diagnostics precision medicine molecular markers immunotherapy antiangiogenic therapy
Online Access:	http://journal.frontiersin.org/article/10.3389/fmed.2017.00063/full

Similar Items

Clinical Impact of two Different Diagnostic Strategies in the First- and Second-Line Treatment of Locally Advanced or Metastatic EGFR-Mutated Non-Small Cell Lung Cancer
by: Giovanni Gancitano, et al.
Published: (2020-02-01)

Implementation of Next Generation Sequencing-Based Liquid Biopsy for Clinical Molecular Diagnostics in Non-Small Cell Lung Cancer (NSCLC) Patients
by: Elisabetta Zulato, et al.
Published: (2021-08-01)

Dual blockade of EGFR and VEGFR pathways: Results from a pilot study evaluating apatinib plus gefitinib as a first‐line treatment for advanced EGFR‐mutant non‐small cell lung cancer
by: Zhonghan Zhang, et al.
Published: (2020-06-01)

Cost-Consequence Analysis of Three Different Diagnostic Strategies in the First- and Second-Line Treatment of Locally Advanced or Metastatic Non-Small-Cell Lung Cancer
by: Giovanni Gancitano, et al.
Published: (2018-05-01)

Effects of microRNA regulation on antiangiogenic therapy resistance in non-small cell lung cancer
by: Chenxi Hu, et al.
Published: (2020-11-01)

Second Line Treatment of Non-Small Cell Lung Cancer: Clinical; Pathological and Molecular Aspects of Novel Promising Drugs
Published: (2017)

Review and perspective on adjuvant and neoadjuvant immunotherapies in NSCLC
by: Yi C, et al.
Published: (2019-09-01)

Promoter Methylation of Selected Genes in Non-Small-Cell Lung Cancer Patients and Cell Lines
by: Victoria Sarne, et al.
Published: (2020-06-01)

Digital Pathology and PD-L1 Testing in Non Small Cell Lung Cancer: A Workshop Record
by: Fabio Pagni, et al.
Published: (2020-07-01)

Required Evidence for Clinical Applications of Liquid Biopsy Using Especially CTCs in Lung Cancer
by: Menno Tamminga, et al.
Published: (2020-05-01)

Are There New Biomarkers in Tissue and Liquid Biopsies for the Early Detection of Non-Small Cell Lung Cancer?
by: Fiorella Calabrese, et al.
Published: (2019-03-01)

Unveiling mutational dynamics in non‐small cell lung cancer patients by quantitative EGFR profiling in vesicular RNA
by: Luigi Pasini, et al.
Published: (2021-09-01)

Molecular signature comprising 11 platelet-genes enables accurate blood-based diagnosis of NSCLC
by: Chitrita Goswami, et al.
Published: (2020-10-01)

Validation of liquid biopsy: plasma cell-free DNA testing in clinical management of advanced non-small cell lung cancer
by: Veldore VH, et al.
Published: (2018-01-01)

Detection of Circulating Tumor Cells in the Diagnostic Leukapheresis Product of Non-Small-Cell Lung Cancer Patients Comparing CellSearch<sup>®</sup> and ISET
by: Menno Tamminga, et al.
Published: (2020-04-01)

Quantitative analysis of cell-free DNA by droplet digital PCR reveals the presence of EGFR mutations in non-malignant lung pathologies
by: Rajesh Venkataram, et al.
Published: (2021-05-01)

Liquid Biopsy Is a Promising Tool for Genetic Testing in Idiopathic Pulmonary Fibrosis
by: Pierlorenzo Pallante, et al.
Published: (2021-07-01)

Update on the types and usage of liquid biopsies in the clinical setting: a systematic review
by: Borros Arneth
Published: (2018-05-01)

The Promise of Liquid Biopsy to Predict Response to Immunotherapy in Metastatic Melanoma
by: Luigi Fattore, et al.
Published: (2021-03-01)

Monitoring HOTTIP levels on extracellular vesicles for predicting recurrence in surgical non-small cell lung cancer patients
by: Bing Han, et al.
Published: (2021-08-01)

Prospective Exploratory Analysis of Angiogenic Biomarkers in Peripheral Blood in Advanced NSCLC Patients Treated With Bevacizumab Plus Chemotherapy: The ANGIOMET Study
by: Eloisa Jantus-Lewintre, et al.
Published: (2021-07-01)

The Prognostic Role of Circulating Tumor Cells (CTCs) in Lung Cancer
by: Joanna Kapeleris, et al.
Published: (2018-08-01)

Molecular Profiling of Malignant Pleural Effusions with Next Generation Sequencing (NGS): Evidence that Supports Its Role in Cancer Management
by: Georgia Ι. Grigoriadou, et al.
Published: (2020-11-01)

Immunotherapy in inoperable stage III non-small cell lung cancer: a review
by: Natasha A Jain, et al.
Published: (2019-06-01)

Neoangiogenesis in Melanoma: An Issue in Biology and Systemic Treatment
by: Davide Quaresmini, et al.
Published: (2020-10-01)

Circulating miR-320a Acts as a Tumor Suppressor and Prognostic Factor in Non-small Cell Lung Cancer
by: Akanksha Khandelwal, et al.
Published: (2021-03-01)

Next-Generation Biomarkers in Multiple Myeloma: Understanding the Molecular Basis for Potential Use in Diagnosis and Prognosis
by: Amro M. Soliman, et al.
Published: (2021-07-01)

Recognizing Prognostic and Predictive Biomarkers in the Treatment of Non-Small Cell Lung Cancer (NSCLC) with Immune Checkpoint Inhibitors (ICIs)
by: Giustini N, et al.
Published: (2021-03-01)

Comparison of Resistance Spectra after First and Second Line Osimertinib Treatment Detected by Liquid Biopsy
by: Balázs Jóri, et al.
Published: (2021-06-01)

Mutated circulating tumor DNA as a liquid biopsy in lung cancer detection and treatment
by: Martyna Filipska, et al.
Published: (2021-06-01)

Angiogenesis and Non Small Cell Lung Cancer
by: Metodieva S
Published: (2008-01-01)

Plasma Extracellular Vesicles Enriched for Neuronal Origin: A Potential Window into Brain Pathologic Processes
by: Maja Mustapic, et al.
Published: (2017-05-01)

Targeted Next-Generation Sequencing of Liquid Biopsy Samples from Patients with NSCLC
by: Hestia Mellert, et al.
Published: (2021-01-01)

Opportunistic infections complicating immunotherapy for non‐small cell lung cancer
by: Ziwei Liu, et al.
Published: (2020-06-01)

Next Generation Sequencing-Based Profiling of Cell Free DNA in Patients with Advanced Non-Small Cell Lung Cancer: Advantages and Pitfalls
by: Riziero Esposito Abate, et al.
Published: (2020-12-01)

Treatment options after sorafenib failure in patients with hepatocellular carcinoma
by: Imane El Dika, et al.
Published: (2017-12-01)

A randomized, controlled trial evaluating the efficacy and safety of BTH1677 in combination with bevacizumab, carboplatin, and paclitaxel in first-line treatment of advanced non-small cell lung cancer
by: Walburga Engel-Riedel, et al.
Published: (2018-02-01)

Duration of immunotherapy in patients with advanced lung adenocarcinoma with negative driver genes: case report and literature review
by: Qinge Shan, et al.
Published: (2020-10-01)

Early Detection of Hyperprogressive Disease in Non-Small Cell Lung Cancer by Monitoring of Systemic T Cell Dynamics
by: Hugo Arasanz, et al.
Published: (2020-02-01)

Combined plasma and tissue genotyping of EGFR T790M benefits NSCLC patients: a real‐world clinical example
by: Bing Wei, et al.
Published: (2019-05-01)